Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Completed 2Active not recruiting 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 65Gastrointestinal 46Thoracic 36Dermatologic 28Breast 25Gynecologic 23Head & Neck 21Lymphoid 14Tumor-Agnostic 13Other solid neoplasm 10Sarcoma 9CNS 9Endocrine 7Other hematologic neoplasm 5NET 4Plasma cell 1Myeloid 1

Conditions

Neuroendocrine Tumors 4Carcinoma, Merkel Cell 2Neoplasms 1Carcinoma, Neuroendocrine 1Carcinoma 1

Interventions

lutetium Lu 177 dotatate 41Everolimus 38Magnetic Resonance Spectroscopy 18Temozolomide 17lanreotide 16gallium Ga 68 dotatate 15Octreotide 14pembrolizumab 13Nivolumab 13Capecitabine 12cabozantinib 11177Lu-octreotide, DOTA(0)-Tyr(3)- 11surufatinib 9pasireotide 9Sunitinib 9Specimen Handling 9Positron Emission Tomography Computed Tomography 93-Iodobenzylguanidine 9Lutetium-177 8Carboplatin 8amino-acid, glucose, and electrolyte solution 6Ipilimumab 6Ga(III)-DOTATOC 6Fluorodeoxyglucose F18 6Etoposide 6Cisplatin 690Y-octreotide, DOTA-Tyr(3)- 6lenvatinib 5copper dotatate CU-64 5Injections 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × avelumab × NET × Clear all
NCT04291885 2026-04-09

I-MAT

Melanoma and Skin Cancer Trials Limited

Phase 2 Active not recruiting
122 enrolled
DermatologicEndocrineNET

Carcinoma, Merkel Cell, Neuroendocrine Tumors

NCT04261855 2026-03-27

GoTHAM

Melanoma and Skin Cancer Trials Limited

Phase 1/2 Active not recruiting
19 enrolled
DermatologicEndocrineNET

Carcinoma, Carcinoma, Merkel Cell, Neuroendocrine Tumors

NCT03278379 2024-12-24

NET-002

Sunnybrook Health Sciences Centre

Phase 2 Completed
17 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT03352934 2022-02-25

AveNEC

Johannes Gutenberg University Mainz

Phase 2 Completed
60 enrolled
EndocrineNET

Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡